Antiandrogenic and antirenotropic effect of spironolactone.
Spironolactone given to male mice in dose 1.5 mg for 21 days produced significant changes not only in the highly androgen dependent seminal vesicles but also in the kidneys. Spironolactone blocked the action of endogenous testosterone in intact mice and led to further significant decrease in seminal vesicles and kidney weight in castrated mice. Such an effect could be due to a blocking of androgenic action of adrenal steroids.
D000311:Adrenal Glands / Q000187:drug effects; D000818:Animals; D002369:Castration; D007668:Kidney / Q000187:drug effects*; D008297:Male; D051379:Mice; D009929:Organ Size; D012669:Seminal Vesicles / Q000187:drug effects*; D013148:Spironolactone / Q000494:pharmacology*; D013739:Testosterone / Q000037:antagonists & inhibitors
D013148:Spironolactone; D013739:Testosterone